CAPTRUST FINANCIAL ADVISORS - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 90 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$2,000
-33.3%
1,0000.0%0.00%
Q1 2022$3,000
-25.0%
1,0000.0%0.00%
Q4 2021$4,000
-20.0%
1,0000.0%0.00%
Q3 2021$5,000
+25.0%
1,0000.0%0.00%
Q2 2021$4,000
+33.3%
1,0000.0%0.00%
Q1 2021$3,000
+50.0%
1,0000.0%0.00%
Q4 2020$2,0000.0%1,0000.0%0.00%
Q3 2020$2,000
-33.3%
1,0000.0%0.00%
Q2 2020$3,000
+50.0%
1,000
+100.0%
0.00%
Q3 2019$2,0000.0%5000.0%0.00%
Q2 2019$2,000500
+2281.0%
0.00%
Q1 2018$0210.00%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Omega Fund Management, LLC 778,230$5,308,0005.22%
BVF INC/IL 3,592,549$24,501,0002.48%
Prosight Management, LP 563,763$3,845,0002.41%
SPHERA FUNDS MANAGEMENT LTD. 800,000$5,456,0000.83%
Virtus ETF Advisers LLC 125,695$857,0000.74%
EAM Investors, LLC 521,460$3,556,0000.59%
Tekla Capital Management LLC 2,087,380$14,236,0000.55%
Orbimed Advisors 5,550,000$37,851,0000.47%
EAM Global Investors LLC 125,635$857,0000.44%
Schonfeld Strategic Advisors LLC 830,637$5,665,0000.42%
View complete list of PIERIS PHARMACEUTICALS INC shareholders